Core Laboratories (NYSE:CLB) shares were down 5.6% on Tuesday . The company traded as low as $81.54 and last traded at $82.48. Approximately 748,982 shares traded hands during trading, an increase of 68% from the average daily volume of 445,295 shares. The stock had previously closed at $87.39.

A number of research analysts have weighed in on CLB shares. ValuEngine raised shares of Core Laboratories from a “hold” rating to a “buy” rating in a research report on Tuesday, September 4th. Edward Jones initiated coverage on shares of Core Laboratories in a research report on Tuesday, September 4th. They set a “buy” rating for the company. Credit Suisse Group cut their price objective on shares of Core Laboratories from $122.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, October 26th. Stifel Nicolaus raised shares of Core Laboratories from a “hold” rating to a “buy” rating and cut their price objective for the company from $117.00 to $110.00 in a research report on Monday, October 29th. Finally, ABN Amro raised shares of Core Laboratories from a “sell” rating to a “buy” rating in a research report on Wednesday, October 31st. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $112.08.

The stock has a market cap of $3.86 billion, a P/E ratio of 41.58, a PEG ratio of 2.56 and a beta of 1.64. The company has a current ratio of 2.31, a quick ratio of 1.85 and a debt-to-equity ratio of 1.83.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, October 24th. The oil and gas company reported $0.64 EPS for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.01. The business had revenue of $182.15 million during the quarter, compared to analyst estimates of $178.11 million. Core Laboratories had a net margin of 13.21% and a return on equity of 68.00%. The firm’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 earnings per share. Equities research analysts predict that Core Laboratories will post 2.31 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Friday, October 19th were paid a $0.55 dividend. The ex-dividend date was Thursday, October 18th. This represents a $2.20 dividend on an annualized basis and a yield of 2.65%. Core Laboratories’s payout ratio is currently 110.00%.

A number of hedge funds and other institutional investors have recently bought and sold shares of CLB. Signaturefd LLC increased its stake in Core Laboratories by 403.7% in the second quarter. Signaturefd LLC now owns 811 shares of the oil and gas company’s stock valued at $102,000 after acquiring an additional 650 shares during the period. Cornerstone Wealth Management LLC bought a new stake in Core Laboratories in the third quarter valued at about $122,000. Capital International Inc. CA bought a new stake in Core Laboratories in the third quarter valued at about $156,000. Parallel Advisors LLC increased its stake in Core Laboratories by 73.3% in the third quarter. Parallel Advisors LLC now owns 1,634 shares of the oil and gas company’s stock valued at $189,000 after acquiring an additional 691 shares during the period. Finally, WMS Partners LLC bought a new stake in Core Laboratories in the second quarter valued at about $202,000.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/11/21/core-laboratories-clb-shares-down-5-6.html.

About Core Laboratories (NYSE:CLB)

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Recommended Story: Call Option

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.